{
"@context": "https://schema.org",
"@graph": [
{
"@type": "WebPage",
"@id": "https://www.fortrea.com/insights/fortrea-oncology-large-enough-serve-uk-engaged-enough-care#webpage",
"url": "https://www.fortrea.com/insights/fortrea-oncology-large-enough-serve-uk-engaged-enough-care",
"name": "Fortrea oncology: Large enough to serve in the UK, engaged enough to care",
"description": "This Fortrea info sheet highlights oncology clinical development capabilities focused on supporting precision oncology clinical trials, biotech oncology partnerships, and adaptive oncology trial delivery across modern cancer research programs. The publication discusses biomarker-driven oncology trials, immuno-oncology clinical trials, oncology outsourcing solutions, and precision medicine oncology approaches designed to support evolving oncology therapeutic development strategies. The publication also highlights collaborative oncology research models, agile biotech collaboration, operational scalability, and integrated oncology expertise supporting efficient oncology trial execution across global development programs. Fortrea supports sponsors through oncology-focused clinical development services designed to strengthen collaboration, improve operational continuity, and support innovation across cancer clinical research activities. By integrating oncology CRO services with precision oncology research and adaptive clinical development strategies, Fortrea supports more efficient oncology trial delivery and stronger development outcomes across complex oncology programs"
},
{
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "Home",
"item": "https://www.fortrea.com"
},
{
"@type": "ListItem",
"position": 2,
"name": "Insights",
"item": "https://www.fortrea.com/insights/"
},
{
"@type": "ListItem",
"position": 3,
"name": "Fortrea oncology: Large enough to serve in the UK, engaged enough to care",
"item": "https://www.fortrea.com/insights/fortrea-oncology-large-enough-serve-uk-engaged-enough-care"
}
]
},
{
"@type": "Organization",
"@id": "https://www.fortrea.com/#organization",
"name": "Fortrea",
"url": "https://www.fortrea.com",
"description": "Fortrea is a global contract research organization built on more than 30 years of experience and one of the earliest CRO legacies in the industry—as Covance, evolving within Labcorp, and now operating as Fortrea. With deep expertise across Phase I–IV clinical trials, Fortrea advances clinical research through a patient-centric approach that prioritizes meaningful outcomes, stronger site–CRO relationships, and operational excellence. Fortrea partners with biopharmaceutical, biotech, and medical device companies to advance therapies through every stage of clinical development. This commitment is further reinforced by the launch of Fortrea Intelligent Technology, enabling smarter, more connected, and data-driven clinical development. Through Fortrea Intelligent Technology, the organization is advancing data-driven, technology-enabled clinical development to improve speed, quality, and patient outcomes. It is shaped by experience, innovation, and a commitment to raising standards in clinical research—focused on accelerating development and helping bring life-changing treatments to patients around the world.",
"logo": "https://www.fortrea.com/sites/default/files/2025-05/fortrea-logo-without-background.png",
"sameAs": [
"https://www.linkedin.com/company/fortrea",
"https://www.threads.net/@fortreacro",
"https://twitter.com/fortrea",
"https://www.youtube.com/@Fortrea/",
"https://www.facebook.com/Fortrea-104143099267108",
"https://www.instagram.com/fortreacro"
]
},
{
"@type": "Article",
"@id": "https://www.fortrea.com/insights/fortrea-oncology-large-enough-serve-uk-engaged-enough-care#infosheet",
"mainEntityOfPage": {
"@id": "https://www.fortrea.com/insights/fortrea-oncology-large-enough-serve-uk-engaged-enough-care#webpage"
},
"headline": "Fortrea oncology: Large enough to serve in the UK, engaged enough to care",
"description": "This Fortrea info sheet highlights oncology clinical development capabilities focused on supporting precision oncology clinical trials, biotech oncology partnerships, and adaptive oncology trial delivery across modern cancer research programs. The publication discusses biomarker-driven oncology trials, immuno-oncology clinical trials, oncology outsourcing solutions, and precision medicine oncology approaches designed to support evolving oncology therapeutic development strategies. The publication also highlights collaborative oncology research models, agile biotech collaboration, operational scalability, and integrated oncology expertise supporting efficient oncology trial execution across global development programs. Fortrea supports sponsors through oncology-focused clinical development services designed to strengthen collaboration, improve operational continuity, and support innovation across cancer clinical research activities. By integrating oncology CRO services with precision oncology research and adaptive clinical development strategies, Fortrea supports more efficient oncology trial delivery and stronger development outcomes across complex oncology programs",
"genre": "Info Sheet",
"author": {
"@type": "Organization",
"name": "Fortrea",
"url": "https://www.fortrea.com/"
},
"publisher": {
"@id": "https://www.fortrea.com/#organization"
},
"datePublished": "2025-05-31",
"dateModified": "2025-05-31",
"encoding": {
"@type": "MediaObject",
"contentUrl": "https://www.fortrea.com/sites/default/files/2025-05/fortrea-oncology-large-enough-uk-engaged-enough-to-care_0.pdf",
"encodingFormat": "application/pdf"
}
}
]
}